Silicon Laboratories Inc. (NASDAQ:SLAB) Receives $187.00 Consensus Price Target from Brokerages

Shares of Silicon Laboratories Inc. (NASDAQ:SLAB – Get Rating) have received a consensus rating of “Moderate Buy” from the ten brokerages that are presently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average 1-year price objective among brokers that have issued ratings on the stock in the last year is $187.00.

A number of equities analysts have recently weighed in on the company. Cowen lowered their target price on Silicon Laboratories from $205.00 to $180.00 in a research note on Thursday, April 28th. Stifel Nicolaus increased their target price on Silicon Laboratories from $200.00 to $210.00 in a research note on Wednesday, April 27th. Morgan Stanley lowered their target price on Silicon Laboratories from $208.00 to $156.00 and set an “equal weight” rating on the stock in a research note on Monday, April 25th. Needham & Company LLC lowered their target price on Silicon Laboratories to $150.00 in a research note on Tuesday. Finally, Cowen lowered their target price on Silicon Laboratories from $205.00 to $180.00 in a research note on Thursday, April 28th.

NASDAQ:SLAB opened at $128.80 on Wednesday. The company has a quick ratio of 8.40, a current ratio of 8.62 and a debt-to-equity ratio of 0.26. The stock’s 50 day moving average price is $140.00 and its two-hundred day moving average price is $152.09. The firm has a market capitalization of $4.71 billion, a price-to-earnings ratio of 2.70 and a beta of 1.20. Silicon Laboratories has a 12-month low of $114.52 and a 12-month high of $211.98.

Silicon Laboratories (NASDAQ:SLAB – Get Rating) last released its quarterly earnings data on Wednesday, April 27th. The semiconductor company reported $0.77 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.43 by $0.34. The firm had revenue of $233.80 million for the quarter, compared to analyst estimates of $226.22 million. Silicon Laboratories had a return on equity of 4.08% and a net margin of 266.91%. The business’s revenue for the quarter was up 48.2% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.65 earnings per share. Equities research analysts expect that Silicon Laboratories will post 2.38 EPS for the current year.

In other Silicon Laboratories news, Director Nina Richardson sold 473 shares of the firm’s stock in a transaction on Friday, April 22nd. The stock was sold at an average price of $129.60, for a total value of $61,300.80. Following the sale, the director now owns 8,171 shares of the company’s stock, valued at approximately $1,058,961.60. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CEO Robert Matthew Johnson sold 5,435 shares of the firm’s stock in a transaction on Monday, June 6th. The shares were sold at an average price of $149.38, for a total value of $811,880.30. Following the completion of the sale, the chief executive officer now directly owns 26,873 shares in the company, valued at approximately $4,014,288.74. The disclosure for this sale can be found here. Insiders have sold 6,908 shares of company stock worth $1,014,631 in the last three months. 1.61% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in the company. Verition Fund Management LLC bought a new position in shares of Silicon Laboratories in the 1st quarter valued at $1,127,000. Neuberger Berman Group LLC lifted its stake in shares of Silicon Laboratories by 866.8% in the 1st quarter. Neuberger Berman Group LLC now owns 34,949 shares of the semiconductor company’s stock valued at $5,250,000 after acquiring an additional 31,334 shares during the last quarter. Advisors Asset Management Inc. lifted its stake in shares of Silicon Laboratories by 27.8% in the 1st quarter. Advisors Asset Management Inc. now owns 1,390 shares of the semiconductor company’s stock valued at $209,000 after acquiring an additional 302 shares during the last quarter. Quantbot Technologies LP bought a new position in shares of Silicon Laboratories in the 1st quarter valued at $640,000. Finally, Dynamic Technology Lab Private Ltd bought a new position in shares of Silicon Laboratories in the 1st quarter valued at $1,454,000. Institutional investors own 99.40% of the company’s stock.

Silicon Laboratories Company Profile (Get Rating)

Silicon Laboratories Inc, a fabless semiconductor company, provides various analog-intensive mixed-signal solutions in the United States, China, and internationally. The company’s products include wireless microcontrollers and sensor products. Its products are used in various electronic products in a range of applications for the Internet of Things (IoT), including connected home and security, industrial automation and control, smart metering, smart lighting, commercial building automation, consumer electronics, asset tracking, and medical instrumentation.

See Also

Receive News & Ratings for Silicon Laboratories Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Silicon Laboratories and related companies with MarketBeat.com’s FREE daily email newsletter.